These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31796840)

  • 21. Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study.
    Kalakheti BK; Singh R; Bhatta NK; Karki A; Baral N
    Kathmandu Univ Med J (KUMJ); 2009; 7(25):11-5. PubMed ID: 19483446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
    Akgül S; Korkmaz A; Yiğit S; Yurdakök M
    Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single-center experience on exchange transfusion therapy in 123 full-term cases of severe neonatal hyperbilirubinemia in Wuhan.
    Duan L; Gan S; Hu H
    J Matern Fetal Neonatal Med; 2021 Feb; 34(3):466-472. PubMed ID: 33225794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO hemolytic disease of the newborn: a need for clarity and consistency in diagnosis.
    Watchko JF
    J Perinatol; 2023 Feb; 43(2):242-247. PubMed ID: 36344813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn.
    Calkins K; Roy D; Molchan L; Bradley L; Grogan T; Elashoff D; Walker V
    J Neonatal Perinatal Med; 2015; 8(3):243-50. PubMed ID: 26518407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "ABO hemolytic disease".
    Smith DW; Stevenson DK
    Clin Pediatr (Phila); 1986 Feb; 25(2):116. PubMed ID: 3943260
    [No Abstract]   [Full Text] [Related]  

  • 27. Overview of neonatal hyperbilirubinemia at Nepal Medical College Teaching Hospital.
    Rijal P; Bichha RP; Pandit BP; Lama L
    Nepal Med Coll J; 2011 Sep; 13(3):205-7. PubMed ID: 22808817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Icterus gravis in ABO incompatibility and bilirubin coupling disorders].
    Stur O
    Wien Med Wochenschr; 1970 May; 120(22):400-1. PubMed ID: 5534805
    [No Abstract]   [Full Text] [Related]  

  • 29. Neonatal jaundice.
    Maisels MJ
    Pediatr Rev; 2006 Dec; 27(12):443-54. PubMed ID: 17142466
    [No Abstract]   [Full Text] [Related]  

  • 30. Racial difference in incidence of ABO hemolytic disease.
    Bucher KA; Patterson AM; Elston RC; Jones CA; Kirkman HN
    Am J Public Health; 1976 Sep; 66(9):854-8. PubMed ID: 961953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of neonatal hyperbilirubinemia: pediatricians' practices and educational needs.
    Petrova A; Mehta R; Birchwood G; Ostfeld B; Hegyi T
    BMC Pediatr; 2006 Mar; 6():6. PubMed ID: 16519797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results.
    Peeters B; Geerts I; Van Mullem M; Micalessi I; Saegeman V; Moerman J
    Eur J Pediatr; 2016 May; 175(5):651-7. PubMed ID: 26782094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
    Senterre T; Minon JM; Rigo J
    Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn screening for ABO hemolytic disease.
    Levine DH; Meyer HB
    Clin Pediatr (Phila); 1985 Jul; 24(7):391-4. PubMed ID: 3924461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HEMOLYTIC DISEASE OF THE NEWBORN INFANT CAUSED BY ABO INCOMPATIBILITY, DIAGNOSTIC VALUE OF THE BIOLOGICAL TESTS IN THE INFANT].
    GUIMBRETIERE J; TOSCER M
    Transfusion (Paris); 1964; 7():191-201. PubMed ID: 14168284
    [No Abstract]   [Full Text] [Related]  

  • 37. Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia.
    Bromiker R; Goldberg A; Kaplan M
    J Perinatol; 2017 Dec; 37(12):1315-1318. PubMed ID: 29192695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.
    Bhutani VK; Stark AR; Lazzeroni LC; Poland R; Gourley GR; Kazmierczak S; Meloy L; Burgos AE; Hall JY; Stevenson DK;
    J Pediatr; 2013 Mar; 162(3):477-482.e1. PubMed ID: 23043681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
    Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK
    Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABO incompatibility and neonatal hyperbilirubinemia.
    Chen SH; Lin KS; Chen CL
    Taiwan Yi Xue Hui Za Zhi; 1985 Nov; 84(11):1233-9. PubMed ID: 3868698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.